World / Cancer
Goshen Center For Cancer Care Doctor Named Naturopathic Physician Of The Year
05.09.2008 20:15
medicalnewstoday.com
Goshen Center for Cancer Care's Director of Integrated Care, Marcia Prenguber, ND, FABNO, has been chosen as the 2008 Naturopathic Physician of the Year by the American Association of Naturopathic Physicians. Dr. Prenguber was honored, and presented with the award, during the AANP's 2008 Annual Convention & Exposition on Aug, 16 at the Arizona Biltmore Resort & Spa in Phoenix, Ariz.
World
Cancer
Scientists Map Complete Genetic Blueprint Of Deadly Cancers
05.09.2008 14:15
medicalnewstoday.com
In what has been heralded as a significant breakthrough in the fight against two of the world's deadliest cancers, US scientists have mapped complete genetic blueprints comprising more than 20,000 genes in 24 pancreatic cancers and 22 brain cancers, including not only individual gene mutations but also their interlinked pathways which sustain tumour development and growth.
World
Cancer
OncoMune Publishes Positive Results Of OCM-8054 - Breast Cancer Dependency On BORIS Unequivocally Demonstrated By RNA Interference
05.09.2008 12:25
medicalnewstoday.com
OncoMune LLC, a biotechnology company focused on developing targeted cancer therapeutics, announced the publication of its preclinical OCM-8054 data. The publication entitled, "Selective apoptosis of breast cancer cells by siRNA targeting of BORIS," appeared in the May 23rd 2008 issue of the scientific journal, Biochemical and Biophysical Research Communications, Volume 370, Issue 1, Pages 109-112.
World
Cancer
Black Women Less Likely Than White Women To Receive Follow-Up Treatments After Breast Cancer Surgery, Study Finds
05.09.2008 12:25
medicalnewstoday.com
Black women who undergo a lumpectomy surgery to treat early-stage breast cancer are less likely than their white counterparts to receive the recommended follow-up radiation therapy treatments, according to study released on Wednesday, Reuters/Boston Globe reports.
World
Cancer
HIV And Prostate Cancer: A Systematic Review Of The Literature
05.09.2008 10:19
medicalnewstoday.com
UroToday.com - In the online edition of Prostate Cancer Prostatic Diseases, Dr. Jonathan Silberstein and his colleagues presented a systematic review of HIV and prostate cancer (CaP). The message that may be underappreciated by the urology community is the excellent longevity of HIV patients, which clearly impacts their potential for diagnosis and management of CaP. In 2003, over one-million people were living with HIV in the US and three quarters of them were men.
World
Cancer
September 13th Is National Childhood Cancer Awareness Day
05.09.2008 08:18
medicalnewstoday.com
A pediatric bone cancer survivor who now is studying to become a pediatric hematologist/oncologist…a childhood leukemia survivor who has walked a mile in the shoes of the young cancer patients she now treats. These are just a few of the hundreds of patients treated through the Pediatric Hematology/Oncology program at The Cancer Institute of New Jersey (CINJ), which is celebrating 15 years of patient care this year.
World
Cancer
Scientists 'Stand Up To Cancer' With Latest Research
05.09.2008 08:18
medicalnewstoday.com
As the Stand Up To Cancer campaign -- being put forth by television's "Big 3" networks -- is opening the nation's eyes to the need and the benefit of cancer research dollars, The Cancer Institute of New Jersey (CINJ) is highlighting some of its groundbreaking studies being conducted by internationally recognized clinical investigators.
World
Cancer
Agendia Launches TargetPrint(R) For Breast Cancer Patients
05.09.2008 08:18
medicalnewstoday.com
Agendia, a world leader in molecular cancer diagnostics, announced the launch of TargetPrint(R), a new diagnostic test that allows physicians to quantitatively determine the gene expression levels of the estrogen receptor (ER), progesterone receptor (PR) and Human Epidermal growth factor Receptor 2 (HER2) in breast cancer tumor biopsies.
World
Cancer
Blacks Less Likely Than Whites To Receive Standard Of Care In Radiation Therapy For Breast Cancer
05.09.2008 08:18
medicalnewstoday.com
Black women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M. D. Anderson Cancer Center. The study, the largest of its kind, was presented in advance of the American Society of Clinical Oncology (ASCO) Breast Cancer Symposium, and is the first national study to examine such racial disparities in radiation therapy.
World
Cancer
Change In HER2 Status After Treatment With Herceptin Discovered By M. D. Anderson Study
05.09.2008 08:18
medicalnewstoday.com
Researchers at The University of Texas M. D. Anderson Cancer Center have discovered that when treated with Herceptin prior to surgery, 50 percent of HER2 positive, breast cancer patients showed no signs of disease at the time of surgery. However, of those women who had residual disease, about one-third had tumors that converted from HER2 positive to HER 2 negative status -possibly indicating a resistance to the targeted therapy.
World
Cancer
Medarex Announces Presentations At The 33rd Congress Of The European Society For Medical Oncology
05.09.2008 06:16
medicalnewstoday.com
Medarex, Inc. (Nasdaq: MEDX) announced that nine clinical abstracts for ipilimumab, an investigational anti-CTLA-4 antibody, in melanoma are scheduled to be the subject of presentations at the 33rd Congress of the European Society for Medical Oncology (ESMO) being held September 12-16, 2008 in Stockholm.
World
Cancer
Azaya Therapeutics Licenses Promising Treatment For Head And Neck Cancers
05.09.2008 06:16
medicalnewstoday.com
Azaya Therapeutics, Inc., announced that it has signed a licensing agreement to further develop a breakthrough technology that uses liposomes to deliver radiation through direct injection into head and neck tumors, shrinking the tumor, delaying recurrence and avoiding the collateral tissue damage that often accompanies all other forms of radiation therapy. The company plans to begin a phase I clinical trial in early 2010.
World
Cancer
News From CA: Cancer Quality Alliance, Blueprint For A Better Cancer Care System
05.09.2008 04:43
medicalnewstoday.com
Cancer Quality Alliance: Blueprint for a Better Cancer Care System In this report, the Cancer Quality Alliance (CQA), a national alliance advocating for improvements in the quality of cancer care in America, presents a set of 5 case studies that depict a vision of quality cancer care and a "Blueprint" for actions to realize this vision.
World
Cancer
Testosterone Administration To Men With Testosterone Deficiency Syndrome After External Beam Radiotherapy For Localized Prostate Cancer
05.09.2008 04:43
medicalnewstoday.com
UroToday.com - Dr. Alvaro Morales and associates from the Centre for Applied Urological Research, reported on the first study on testosterone deficiency syndrome (TDS) in men treated with radiotherapy for prostate cancer. Five men with clinically localized CaP were prospectively studied. The mean Gleason sum was 7 and mean PSA level before radiotherapy was 12.8ng/ml. The mean PSA before testosterone replacement therapy (TRT) was 0.3ng/ml.
World
Cancer
Cytopia Commences Second Phase II Study In Brain Cancer
05.09.2008 04:43
medicalnewstoday.com
Cytopia Limited (ASX:CYT) announced that it is commencing enrolment for its Phase Ib/II study of CYT997, the company's novel vascular-disrupting anticancer agent, in patients with an aggressive form of brain cancer known as glioblastoma multiforme (GBM). The GBM clinical trial is the first Phase II efficacy study in highly vascular, solid tumour indications for the company and the second in its suite of Phase II studies designed to investigate the anti-cancer activity of CYT997.
World
Cancer
English